Thyroid hormone transport and actions

Pediatric and Adolescent Medicine

Volumn 11, Issue , 2007, Pages 80-103

  Feldt Rasmussen, Ulla ^a,b   Rasmussen, Åse Krogh ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954873362     PISSN: 10175989     EISSN: 16623886     Source Type: Book Series    
DOI: 10.1159/000098021     Document Type: Article

References (109)

1. Refetoff S: Inherited thyroxine-binding globulin (TBG) abnormalities in man. Endocr Rev 1989;10:275-293. (Pubitemid 19223061)
2. Refetoff S: Thyroid hormone serum transport proteins: Structure, properties and genes and transcriptional regulation. http://www.thyroidmanager. org/chapter3a.
3. Chan V, Besser GM, Landon J: Effects of oestrogen on urinary thyroxine excretion. Br Med J 1972;iv:699-701.
4. Pemberton PA, Stein PE, Pepys MB, Potter JM, Carell RW: Hormone binding globulins undergo serpin conformational change in inflammation. Nature 1988;336:257-258. (Pubitemid 18264407)
5. Hocman G: Human thyroxine binding globulin. Rev Physiol Biochem Pharmacol 1981;81:45-88.
6. Stubbe P, Gatz J, Heidemann P, Muhlen ARG, Hesch R: Thyroxine-binding globulin, triiodothyronine, thyroxine and thyrotropin in newborn infants and children. Horm Metab Res 1978;10:58-61. (Pubitemid 8283925)
7. Ain KB, Mori Y, Refetoff S: Reduced clearance rate of thyroxine-binding globulin (TBG) with increased sialylation: a mechanism for estrogen induced elevation of serum TBG concentration. J Clin Endocrinol Metab 1987;65:689-696. (Pubitemid 17157386)
8. Federman DD, Robbins J, Rall JE: Effects of methyl testosterone on thyroid function, thyroxine metabolism, and thyroxine-binding protein. J Clin Invest 1958;37:1024-1030.
9. Beierwalters WH, Robbins J: Familial increase in the thyroxine-binding sites in serum alpha globulin. J Clin Invest 1959;38:1683-1688.
10. Refetoff S: Inherited thyroxine binding globulin (TBG) abnormalities in man. Endocr Rev 1989;10:275-293. (Pubitemid 19223061)
11. Trent JM, Flink IL, Morkin E, Van Tuinen P, Ledbetter DH: Localization of the human thyroxinebinding globulin gene to the long arm of the X chromosome (Xq21-22). Am J Hum Genet 1987;41:428-435. (Pubitemid 18047473)
12. Macchia PE, Harrison HH, Scherberg NH, Sunthornthepvarakul T, Jaeken J, Refetoff S: Thyroid function tests and characterization of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type I. J Clin Endocrinol Metab 1995;80:3744-3749.
13. Reilly CP, Wellby ML: Slow thyroxine-binding globulin in the pathogenesis of increased dialyzable fraction of thyroxine in nonthyroidal illnesses. J Clin Endocrin Metab 1983;57:15-18. (Pubitemid 13065437)
14. Bartalena L, Farsetti A, Flink IL, Robbins J: Effects of interleukin-6 on the expression of thyroidhormone binding protein genes in cultured hepatoblastoma-derived (Hep G2) cells. Mol Endocrinol 1992;6:935-942.
15. Oppenheimer JH: Role of plasma proteins in the binding, distribution, and metabolism of thyroid hormones. N Engl J Med 1968;278:1153-1162.
16. Hollander CS, Bernstein G, Oppenheimer JH: Abnormalities of thyroxine binding in analbuminemia. J Clin Endocrinol Metab 1968;28:1064-1066.
17. Benvenga S, Robbins J: Lipoprotein-thyroid hormone interactions. TEM 1993;4:194-198. (Pubitemid 23277933)
18. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, Li Vosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR; Guidelines Committee, National Academy of Clinical Biochemistry: Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126.
19. Hennemann G, Docter R, Friesema ECH, de Jong M, Krenning EP, Visser TJ: Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev 2001;22:1206-1211.
20. Friesema ECH, Jansen J, Visser TJ: Thyroid hormone receptors. Biochem Soc Trans 2005;33:228-232.
21. Jansen J, Friesema ECH, Milici C, Visser TJ: Thyroid hormone transporters in health and disease. Thyroid 2005;15:757-768. (Pubitemid 41339256)
22. Hennemann G, Visser TJ: Cellular uptake of thyroid hormone. http://www.thyroidmanager.org/chapter3B.
23. Hagenbuch B: Molecular properties of hepatic uptake systems for bile acids and organic anions. J Membr Biol 1997;160:1-8. (Pubitemid 27491717)
24. Kullak-Ublick GA: Regulation of organic anion and drug transporters of the sinusoidal membrane. J Hepatol 1999;31:563-573. (Pubitemid 29408745)
25. Pizzagalli F, Hagenbuch B, Stieger B, Klenk U, Folkers G, Meier PJ: Identification of novel human organic transporting polypeptide as a high affinity thyroxine transporter. Mol Endocrinol 2002;16:2283-2296. (Pubitemid 35155540)
26. Sugiyama K, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H, Sugiyama Y: Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood brain barrier: High affinity transporter for thyroxine. J Biol Chem 2003;278:43489-43495. (Pubitemid 37345972)
27. Tohyama K, Kusuhara H, Sugiyama Y: Involvement of multispecific organic anion transporter (Slc21a14) in the transport of thyroxine across the blood-brain barrier. Endocrinol 2004;145:4384-4391. (Pubitemid 39120588)
28. Friesema EC, Docter R, Moerings EP, Stieger B, Hagenbuch B, Meier PJ, Krenning EP, Hennemann G, Visser TJ: Identification of thyroid hormone transporters. Biochem Biophys Res Commun 1999;254:497-501. (Pubitemid 29290429)
29. Friesema EC, Docter R, Moerings EPCM, Hagenbuch B, Stieger B, Meier PJ, Krenning EP, Hennemann G, Visser TJ: Identification of rat and human thyroid hormone transporters (abstract). J Endocrinol Invest 1999;22(suppl):18.
30. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 2001;120:525-533. (Pubitemid 32147650)
31. Fujiwara K, Adachi H, Nishio T, Unno M, Tokui T, Okabe M, Onogawa T, Suzuki T, Asano N, Tanemoto M, Seki M, Shiiba K, Suzuki M, Kondo Y, Nunoki K, Shiosegawa T, Iinuma K, Ito S, Matsuno S, Abe T: Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology 2001;142:2005-2012. (Pubitemid 32405959)
32. Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M, Nomura H, Hebert SC, Matsuno S, Kondo H, Yawo H: Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem 1998;273:22395-22401. (Pubitemid 28399802)
33. Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H: Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem 1999;274:17159-17163.
34. Cattori V, Hagenbuch B, Hagenbuch N, Stieger B, Ha R, Winterhalter KE, Meier PJ: Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full-length isoform of the liverspecific transporter-1 (rlst-1) in rat liver. FEBS Lett 2000;474:242-245. (Pubitemid 30330842)
35. Mikkaichi T, Suzuki T, Onogawa T, Tanemoto M, Mizutamari H, Okada M, Chaki T, Masuda S, Tokui T, Eto N, Abe M, Satoh F, Unno M, Hishinuma T, Inui K, Ito S, Goto J, Abe T: Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc Natl Acad Sci USA 2004;101:3569-3574. (Pubitemid 38338236)
36. Suzuki T, Onogawa T, Asano N, Mizutamari H, Mikkaichi T, Tanemoto M, Abe M, Satoh F, Unno M, Nunoki K, Suzuki M, Hishinuma T, Goto J, Shimosegawa T, Matsuno S, Ito S, Abe T: Identification and characterization of novel rat and human gonad-specific organic anion transporters. Mol Endocrinol 2003;17:1203-1215. (Pubitemid 36819945)
37. Friesema EC, Docter R, Moerings EP, Verrey F, Krenning EP: Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinol 2001;142:4339-4348. (Pubitemid 32907062)
38. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ: Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 2003;278:40128-40135. (Pubitemid 37248580)
39. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP, Visser TJ: The association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 2004;364:1435-1437. (Pubitemid 39370719)
40. Lakshmanan M, Goncalves E, Lessly G, Foti D, Robbins J: The transport of thyroxine into mouse neuroblastoma cells, NB41A3: the effect of L-system amino acids. Endocrinology 1990;26:3245-3250. (Pubitemid 20216589)
41. Blondeau JP, Beslin A, Chantoux F, Francon J: Triiodothyronine is a high-affinity inhibitor of amino acid transport system L1 in cultured astrocytes. J Neurochem 1993;60:1407-1413. (Pubitemid 23088316)
42. Zhou Y, Samson M, Osty J, Francon J, Blondeau JP: Evidence for a close link between the thyroid hormone transport system and the aromatic amino acid transport system T in erythrocytes. J Biol Chem 1990;265:17000-17004.
43. Zhou Y, Samson M, Francon J, Blondeau JP: Thyroid hormone concentrative uptake in rat erythrocytes. Involvement of the tryptophan transport system T in countertransport of tri-iodothyronine and aromatic amino acids. Biochem J 1992;281:81-86.
44. Yan Z, Hinkle PM: Saturable, stereospecific transport of 3, 5, 3'-triiodo-L-thyronine and L-thyroxine into GH4C1 pituitary cells. J Biol Chem 1993;268:20179-20184. (Pubitemid 23278919)
45. Ritchie JW, Shi YB, Hayashi Y, Baird FE, Muchekehu RW, Christie GR, Taylor PM: A role for thyroid hormone transporters in transcriptional regulation by thyroid hormone receptors. Mol Endocrinol 2003;17:653-661. (Pubitemid 36403577)
46. Ritchie JW, Taylor PM: Role of the system L permease LAT1 in amino acíd and iodothyronine transport in placenta. Biochem J 2001;356:719-725. (Pubitemid 32588443)
47. Lafreniere RG, Carrel L, Willard HF: A novel membrane transporter encoded by the XPT gene in Xq13.2. Hum Mol Genet 1994;3:1133-1139. (Pubitemid 24211959)
48. Dumitrescu AM, Liao XH, Best TB, Brockman K, Refetoff S: A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 2004;74:168-175. (Pubitemid 38085248)
49. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, Bauer K: The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormonesensitive neuron populations. Endocrinology 2005;146:1701-1706. (Pubitemid 40396877)
50. Kuiper GGJM, Kester MHA, Peeters RP, Visser TJ: Biochemical mechanisms of thyroid hormone deiodination. Thyroid 2005;15:787-798. (Pubitemid 41339259)
51. Ishii H, Inada M, Tanaka K, Mashio Y, Naito K, Nishikawa M, Imura H: Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue. J Clin Endocrinol Metab 1981;52:1211-1217. (Pubitemid 13237527)
52. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR: Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002;23:38-89. (Pubitemid 34185306)
53. Visser TJ: Importance of deiodination and conjugation in the hepatic metabolism of thyroid hormone; in Greer MA (ed): The Thyroid Gland. New York, Raven Press, 1990, pp 255-283.
54. Visser TJ: Role of sulfation in thyroid hormone metabolism. Chem Biol Interact 1994;92:293-303. (Pubitemid 24220216)
55. Oppenheimer JH, Schwartz HL, Surks MI: Propylthiouracil inhibits the conversion of L-thyroxine to L-triiodothyronine: an explanation of the antithyroxine effect of propylthiouracil and evidence supporting the concept that triiodothyronine is the active hormone. J Clin Invest 1972;51:2493-2497.
56. Leonard JL, Koehrle J: Intracellular Pathways of Iodothyronine Metabolism. Philadelphia, Lippincott Williams & Wilkins, 2000.
57. Feldt-Rasmussen U, Hyltoft Petersen P, Blaabjerg O, Horder M: Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol (Copenh). 1980;95:328-334. (Pubitemid 11211727)
58. Browning MC, Ford RP, Callaghan SJ, Fraser CG: Intra-and interindividual biological variation of five analytes used in assessing thyroid function: Implications for necessary standards of performance and the interpretation of results. Clin Chem 1986;32:962-966. (Pubitemid 17021157)
59. Andersen S, Pedersen KM, Bruun NH, Laurberg P: Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 2002;87:1068-1072. (Pubitemid 36121067)
60. Hansen PS, Brix TH, Sorensen TI, Kyvik KO, Hegedüs L: Major genetic influence on the regulation of the pituitary thyroid axis: a study of healthy Danish twins. J Clin Endocrinol Metab 2004;89:181-1187.
61. Samollow PB, Perez G, Kammerer CM, Finegold D, Zwartjes PW, Havill LM, Comuzzie AG, Hahaney MC, Goring HH, Blangero J, Foley TP, Barmada MM: Genetic and environmental influences on thyroid hormone variation in Mexican Americans. J Clin Endocrinol Metab 2004;89:3276-3284. (Pubitemid 38951893)
62. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG, Visser TJ: Polymorphism in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 2003;88:2880-2888. (Pubitemid 36724470)
63. Peeters RP, van den Beld AW, van Toor H, Uitterlinden AG, Janssen JA, Lamberts SW, Visser TJ: A polymorphism in type I deiodinase is associated with circulating free IGF-I levels and body composition in humans. J Clin Endocrinol Metab 2005;90:256-263. (Pubitemid 40116666)
64. Donda A, Lemarchand-Beraud T: Aging alters the activity of 5'-deiodinase in the adenohypophysis, thyroid gland and liver of the male rat. Endocrinology 1989;124:1305-1309. (Pubitemid 19082700)
65. Olivieri O, Girelli D, Stanzial AM, Rossi L, Bassi A, Corrocher R: Selenium, Zink, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biol Trace Elem Res 1996;51:31-41. (Pubitemid 126425224)
66. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, Poehlman ET, Schuldiner AR, Celi FS: Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the beta-3-adrenergic receptor. Diabetes 2002;51:880-883. (Pubitemid 34760206)
67. Koenig RJ: Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid 2005;8:835-840. (Pubitemid 41339262)
68. Toft AD: Clinical practice: subclinical hyperthyroidism. N Engl Med 2001;345:512-516.
69. Cooper DS: Clinical practice: subclinical hypothyroidism. N Engl J Med 2001;345:260-265.
70. Kvicala J, Zamrazil V: Effect of iodine and selenium on thyroid function. Cent Eur J Public Health 2003;11:107-113. (Pubitemid 36829880)
71. van Bakel MM, Prontzen G, Wermuth B, Wiesmann UN: Antioxidant and thyroid hormone status in selenium-deficient phenylketonuric and hyperphenylalaninemic patients. Am J Clin Nutr 2000;72:976-981.
72. Olivieri O, Girelli D, Azzini M, Stanzial AM, Russo C, Ferroni M, Corrocher R: Low selenium status in the elderly influences thyroid hormones. Clin Sci (Lond) 1995;89:637-642.
73. Calomme M, Vanderpas J, Francois B, Van Caillie-Bertrand M, Vanovervelt N, Van Hoorebeke C, Van den Berghe D: Effect of selenium supplementation on thyroid hormone action: trends in metabolism in phenylketonuria subjects on a phenylalanine restricted diet. Biol Trace Elem Res 1995;47:349-353.
74. Contempre B, Duale NL, Dumont JE, Ngo B, Diplock AT, Vanderpas J: Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin Endocrinol (Oxf) 1992;36:579-583.
75. Contempre B, Dumont JE, Ngo B, Thilly CH, Diplock AT, Vanderpas J: Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J Clin Endocrinol Metab 1991;73:213-215. (Pubitemid 21901125)
76. Roti E, Minelli R, Gardini E, Bianconi L, Ronchi A, Gatti A, Minoia C: Selenium administration does not cause thyroid insufficiency in subjects with mild iodine insufficiency and sufficient selenium intake. J Endocrinol Invest 1993;16:481-484. (Pubitemid 23275970)
77. Köhrle J: Selenium and the control of thyroid hormone metabolism. Thyroid 2005;15:841-853. (Pubitemid 41339263)
78. Reid ME, Stratton MS, Lillico AJ, Fakin M, Natarajan R, Clark LC, Marshall JR: A report of high dose selenium supplementation: response and toxicities. J Trace Elem Med Biol 2004;18:69-74. (Pubitemid 39285967)
79. McIver B, Gorman CA: Euthyroid sick syndrome: an overview. Thyroid 1997;7:125-132. (Pubitemid 27132906)
80. Faber J, Siersbaek-Nielsen K: Serum free 3, 5, 3'-triiodothyronine (T3) in non thyroidal illness, as measured by ultrafiltration and immunoextraction. Clin Chem Acta 1996;256:115-123. (Pubitemid 27055801)
81. Faber J, Thomsen HF, Lumholtz IB, Kirkegaard C, Siersbaek-Nielsen K, Friis T: Kinetic studies of thyroxine, 3, 5, 3'-triiodothyronine, 3, 3, 5'-triiodothyronine, 3', 5'-diiodothyronine, and 3'-monoiodothyronine in patients with liver cirrhosis. J Clin Endocrinol Metab 1981;53:978-984. (Pubitemid 13229578)
82. Kaptein EM, Robinson WJ, Grieb DA, Nicoloff JT: Peripheral serum thyroxine, triiodothyronine and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illness: a noncompartmental analysis. J Clin Invest 1982;69:526-535. (Pubitemid 12184948)
83. Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga W: Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3, 5, 3'-triiodothyronine syndrome. Endocrinology 1996;137:5250-5254.
84. Torpy DJ, Tsigos C, Lotsiaks AJ, Defensor R, Chrousos GP, Papanicolau DA: Acute and delayed effects of a single dose of interleukin-6 on thyroid function in healthy humans. Metabolism 1998;47:1289-1293. (Pubitemid 28469259)
85. Van den Berghe G, Wouters P, Bowers CY, de Zegher F, Bouillon R, Veldhuis JD: Growth hormone releasing peptide-2 infusion synchronises growth hormone, thyrotropin and prolactin release in prolonged critical illness. Eur J Endocrinol 1999;140:17-22. (Pubitemid 29074762)
86. Van den Berghe G, Baxter RC, Weekers F et al: The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 2002;56:655-669. (Pubitemid 34595735)
87. Baur A, Bauer K, Jarry H, Koehrle J: Effects of proinflammatory cytokines on anterior pituitary 5'-deiodinase type I and II. J Endocrinol 2000;167:505-515. (Pubitemid 32047558)
88. Davis PJ, Davis FB: Nongenomic actions of TH. Thyroid 1996;6:497-504.
89. Yen PM: Physiological and molecular basis of thyroid hormone action. Physiol Rev 2001;81:1097-1142. (Pubitemid 32606667)
90. Davis PJ, Davis FB, Cody V: Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab 2005;16:429-435. (Pubitemid 41506950)
91. Bassett JHD, Harvey CB, Williams GR: Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol 2003;213:1-11. (Pubitemid 38229150)
92. Kahaly GJ, Dillmann WH: Thyroid hormone action in the heart. Endocr Rev 2005;26:704-728. (Pubitemid 41127279)
93. Harvey CB, Williams GR: Mechanism of thyroid hormone action. Thyroid 2002;12:441-446. (Pubitemid 34721538)
94. Zhang J, Lazar MA: The mechanism of action of thyroid hormones. Annu Rev Physiol 2000;62:439-466. (Pubitemid 30618270)
95. Aranda A, Pascual A: Nuclear hormone receptors and gene expression. Physiol Rev 2001;81:1269-1304. (Pubitemid 32606670)
96. Yen PM: Cellular action of thyroid hormone. http://www.thyroidmanager. org/chapter3d.
97. Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, Vennstrom B, Forrest D: Mice devoid of all known TH receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 1999;13:1329-1341. (Pubitemid 29250200)
98. Davis PJ, Davis FB: Nongenomic actions of thyroid hormone on the heart. Thyroid 2002;12:459-466. (Pubitemid 34721541)
99. Lin HY, Davis FB, Gordinier JK, Martino LJ, Davis PJ: Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am J Physiol 1999;276:C1014-C1024. (Pubitemid 29244654)
100. Storey NM, O'Bryan JP, Armstrong DL: Rac and Rho mediate opposing hormonal regulation of the ether-a-go-go-related potassium channel. Curr Biol 2002;12:27-33. (Pubitemid 34063350)
101. Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ: Integrin αVβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology 2005;146:2864-2871. (Pubitemid 41002793)
102. Mousa SA, O'Connor LJ, Bergh JJ, Davis FB, Scanlan TS, Davis PJ: The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin. J Cardiovasc Pharmacol 2005;46:356-360. (Pubitemid 41262839)
103. Mousa SA, O'Connor L, Davis FB, Davis PJ: Proangiogenesis action of the thyroid hormone analog 3, 5-diiodothyropropionic acid, (DITPA) is initiated at the cell surface and is integrin mediated. Endocrinology 2006;147:1602-1607.
104. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascarelli S, Crossley DA, Bunzow JR, Ronca-Testoni S, Lin ET, Hatton D, Zucchi R, Grandy DK: 3-Iodithyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 2004;10:638-662.
105. Morkin E, Ladenson P, Goldman S, Adamson C: Thyroid hormone analogs for treatment of hypercholesterolemia and heart failure: past, present and future prospects. J Mol Cell Cardiol 2004;37:1137-1146. (Pubitemid 39585161)
106. Morkin E, Pennock GD, Spooner PH, Bahl JJ, Goldman S: Clinical and experimental studies on the use of 3, 5-diiodothyropropionic acid, a thyroid hormone analogue, in heart failure. Thyroid 2002;12:57-533.
107. Casas F, Daury L, Grandemange S, Busson M, Seyer P, Hatier R, Carazo A, Cabello G, Wrutniak-Cabello C: Endocrine regulation of mitochondrial activity: involvement of truncated RXRalpha and c-Erb Alpha1 proteins. FASEB J 2003;17:426-436. (Pubitemid 36292958)
108. Sterling K, Brenner MA: Thyroid hormone action: effect of triiodothyronine on mitochondrial adenine nucleotide translocase in vivo and in vitro. Metabolism 1995;44:193-199.
109. Yen PM: Thyroid Hormones and 3, 5-diiodothyropropionic acid: new keys for new locks. Endocrinology 2006;147:1598-1601.